Redx Pharma PLC - Macclesfield, England-based treatments for cancer and fibrotic disease - Hires Jane Robertson as chief medical officer, starting March 1, 2021. Robertson joins from Achilles Therapeutics Ltd, a biotech company where she also is chief medical officer. In the past, she worked in research & development for oncology at AstraZeneca PLC. Robertson replaces Andrew Saunders, who is leaving Redx after three years "to pursue other opportunities".
Current stock price: 69.45 pence
Year-to-date change: sharply up from 8.25p on December 31
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
